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Liquid‐ﬁlled hard gela/n capsules:  
excipient/capsule compa/bility studies 

______________________________ 
INTRODUCTION 
 
Encapsula t ion of pharmaceut ica l 
formulations as liquids or semisolids, 
within hard gelatin capsules, presents an 
important oral dosage strategy for poorly 
water-soluble drugs, resulting in good 
bioavailability and reproducible drug 
absorption [1]. In addit ion, this 
technology offers an inherently safer 
process than powder filled capsules and 
tablets for highly potent or cytotoxic 
drugs by avoiding dust generation. 
 
Gelatin is a mixture of water-soluble 
proteins and as such is chemically not 
inert. Crosslinking can occur as a result of 
elevated temperature, humidity, UV light 
and/or presence of aldehydes. Certain 
excipients used in the formulation of 
liquid filled capsules may have, or may 
generate during storage, low levels of 
aldehydes, which can potentially react 
with gelatin. Crosslinking can cause 
considerable changes in the dissolution 
profile of gelatin capsules. 
 
Moisture within the gelatin capsules acts 
as a plasticiser for gelatin. Hygroscopic 
materials, when filled into the capsule, 
can extract moisture from the shell and 
thereby induce capsule brittleness, which 
in turn reduces the robustness of the 
capsule product.  
 
Here we present a compatibility study of 
hard gelatin capsules with common 
excip ients in absence of ac t ive 
pharmaceutical. 
 
______________________________ 
MATERIAL AND METHODS 
 
Capsugel Licaps were filled with 
excipients and stored at 5¡C, 25¡C/60% 
relative humidity (%RH) and 40¡C/
75%RH. Mass increase of the filled 
capsules during storage was determined 
gravimetrically. Capsule dissolution 
behaviour in 0.1M HCl was assessed 
visually using a Caleva 10ST dissolution 
apparatus (37¡C; paddle speed: 99 rpm).  
 
 
 
 
 
 
______________________________ 
RESULTS AND DISCUSSION 
 
Weight increase of capsules containing 
excipients are displayed in Fig. 1. PEG 
300, which is known to be hygroscopic, 
shows the highest weight increase at 5¡C 
and 25¡C. Addition of Tocopherol 
(Vitamin E) to the PEG300/1500 mixture 
reduced the weight increase. Weight 
increase was lowest for capsules filled 
with Gelucire 44/14. 
 
After 6 month storage at 40¡C/75%RH 
only the capsules containing Gelucire, 
Kollisolv/PEG300 and the PEG1500/300 
mixture with Tocopherol had fully 
dissolved after 90 min in the dissolution 
vessel. Capsule shells were only partially 
dissolved when filled with Labrasol, 
PEG300 and the PEG mixture without 
Tocopherol, indicating gelatin cross-
linking during storage.  
 
______________________________ 
CONCLUSIONS 
 
 Simple weight checks under stressed 
conditions give useful insights into 
excipient/capsule compatibility. 
 Presence of antioxidants can add to 
improved capsule excipient 
compatibility by preventing 
crosslinking of gelatin.  
 
______________________________ 
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Figure 1:  
Weight change of Licaps gelatin capsules 
filled with excipients in absence of drug stored 
at controlled conditions: 5¡C, 25¡C/60% RH, 
40¡C/75%RH. 
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